GB1493380A — Thiadiazolyl-azo dyestuffs
Assigned to Novartis AG · Expires 1977-11-30 · 48y expired
What this patent protects
1493380 N-Chlorocyanoformamidine and aminothiadiazole derivatives prepared therefrom CIBA-GEIGY AG 11 Dec 1974 [21 Dec 1973] 53668/74 Heading C2C [Also in Division C4] N-Chlorocyanoformamidine [NC-C(NH 2 ) = N-Cl] is prepared from N-chlorocyanoformimide acid chloride and ammonia …
USPTO Abstract
1493380 N-Chlorocyanoformamidine and aminothiadiazole derivatives prepared therefrom CIBA-GEIGY AG 11 Dec 1974 [21 Dec 1973] 53668/74 Heading C2C [Also in Division C4] N-Chlorocyanoformamidine [NC-C(NH 2 ) = N-Cl] is prepared from N-chlorocyanoformimide acid chloride and ammonia (Preparation (a)). 3-Cyano-5-amino-1,2,4-thiadiazole is prepared from N-chlorocyanoformamidine and potassium thiocyanate in methanol by cyclization (Preparation (b)). 3-Trichloromethyl-5-amino-1,2,4-thiadiazole is prepared from N-chloro-trichloroacetamidine and potassium thiocyanate as above (Preparation (c)).
Drugs covered by this patent
- Velsipity (Etrasimod Arginine) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.